microlax

Medicinal product

(Invented) name

microlax

Active substance (s)

Sorbitolis/Natrio citratas dihidratas/Natrio laurilsulfoacetatas

Strength

625 mg/90 mg/9 mg/ml

Pharmaceutical form

tiesiosios žarnos tirpalas

Route (s) of administration

vartoti į tiesiąją žarną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

A06AG11, sodium lauryl sulfoacetate, incl. combinations

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2021-09-27

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Sorbitolis	625 mg
Natrio citratas dihidratas	90 mg
Natrio laurilsulfoacetatas	9 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107276	93380	1093380	tūbelė	5 ml N12		Nereceptinis	LT/L/21/1596/001	Netiekiama	2025-10-13	-	No	-	-	Download

Stadijos

Data	Stadija
2021-09-27	Registruotas